Sowell Financial Services’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-65
Closed -$4K 2759
2020
Q2
$4K Sell
65
-352
-84% -$32.2K ﹤0.01% 2006
2020
Q1
$31K Buy
+417
New +$48K ﹤0.01% 1239

Other funds holding ORTX

Sowell Financial Services's ORTX Position: Q3 2020 in Review

Sowell Financial Services sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2020, closing a stake of 65 shares — an estimated $4K sold.

Sowell Financial Services first reported a position in ORTX in Q1 2020 and held it in 2 quarters. The position peaked at $31K in Q1 2020. 72 funds tracked by Wall St. Rank hold ORTX as of Q3 2020.

  • Sowell Financial Services reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
  • Sowell Financial Services sold 65 Orchard Therapeutics plc American Depositary Shares shares in Q3 2020, an estimated $4K.
  • Sowell Financial Services first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2020 and held it in 2 quarters.
  • Sowell Financial Services's Orchard Therapeutics plc American Depositary Shares position peaked at $31K in Q1 2020.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2020.

Based on Sowell Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.